Atrial Fibrillation: An Adverse Prognostic Indicator for Individuals with Dilated Cardiomyopathy
Haukka Cammann1*, Ben Levitt1, Scarsini Alberto2, Anttila Mansky3
1Department of Cardiology and Nephrology, Helios Klinikum, Berlin-Buch, 13125 Berlin, Germany.
2German Society of Cardiologists in Private Practise (BNK), 10627 Berlin, Germany.
3Clinic for Acute and Emergency Medicine, St. Antonius Hospital Eschweiler, 52249 Eschweiler, Germany.
Correspondence to: Haukka Cammann, Department of Cardiology and Nephrology, Helios Klinikum, Berlin-Buch, 13125 Berlin, Germany. E-mail: haukka_cammann@charite.de
Received: February 03, 2023; Accepted: February 22, 2023; Published: February 28, 2023
Citation: Cammann H, Levitt B, Alberto S, Mansky A. Atrial Fibrillation: An Adverse Prognostic Indicator for Individuals with Dilated Cardiomyopathy. J Cardiol Cardiovasc Dis. 2023;1(1):1-7.
Copyright: © 2023 Cammann H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
